Clinical blockade of PD1 and LAG3-potential mechanisms of action

被引：502

作者：

Nguyen, Linh T. ^{[1
]}

Ohashi, Pamela S. ^{[1
]}

机构：

[1] Princess Margaret Canc Ctr, Immune Therapy Program, Toronto, ON M5G 2M9, Canada

来源：

NATURE REVIEWS IMMUNOLOGY | 2015年 / 15卷 / 01期

关键词：

T-CELL-ACTIVATION; CHRONIC VIRAL-INFECTION; LYMPHOCYTE-ACTIVATION; PROGRAMMED DEATH-1; PHASE-I; ADVANCED MELANOMA; IMMUNE-RESPONSES; PD-1; EXPRESSION; B-CELLS; INHIBITORY RECEPTORS;

D O I：

10.1038/nri3790

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Dysfunctional T cells can render the immune system unable to eliminate infections and cancer. Therapeutic targeting of the surface receptors that inhibit T cell function has begun to show remarkable success in clinical trials. In this Review, we discuss the potential mechanisms of action of the clinical agents that target two of these receptors, programmed cell death protein 1 (PD1) and lymphocyte activation gene 3 protein (LAG3). We also suggest correlative studies that may define the predominant mechanisms of action and identify predictive biomarkers.

引用

页码：45 / 56

页数：12

共 125 条

[1] SELECTION OF GENETIC-VARIANTS OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS IN SPLEENS OF PERSISTENTLY INFECTED MICE - ROLE IN SUPPRESSION OF CYTO-TOXIC LYMPHOCYTE-T RESPONSE AND VIRAL PERSISTENCE [J].

AHMED, R ;

SALMI, A ;

BUTLER, LD ;

CHILLER, JM ;

OLDSTONE, MBA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (02) :521-540

[2] Role Played by the Programmed Death-1-Programmed Death Ligand Pathway during Innate Immunity against Mycobacterium tuberculosis [J].

Alvarez, Ivana B. ;

Pasquinelli, Virginia ;

Jurado, Javier O. ;

Abbate, Eduardo ;

Musella, Rosa M. ;

de la Barrera, Silvia S. ;

Garcia, Veronica E. .

JOURNAL OF INFECTIOUS DISEASES, 2010, 202 (04) :524-532

[3] Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial [J].

Armand, Philippe ;

Nagler, Arnon ;

Weller, Edie A. ;

Devine, Steven M. ;

Avigan, David E. ;

Chen, Yi-Bin ;

Kaminski, Mark S. ;

Holland, H. Kent ;

Winter, Jane N. ;

Mason, James R. ;

Fay, Joseph W. ;

Rizzieri, David A. ;

Hosing, Chitra M. ;

Ball, Edward D. ;

Uberti, Joseph P. ;

Lazarus, Hillard M. ;

Mapara, Markus Y. ;

Gregory, Stephanie A. ;

Timmerman, John M. ;

Andorsky, David ;

Or, Reuven ;

Waller, Edmund K. ;

Rotem-Yehudar, Rinat ;

Gordon, Leo I. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (33) :4199-4206

[4] B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells [J].

Azuma, Takeshi ;

Yao, Sheng ;

Zhu, Gefeng ;

Flies, Andrew S. ;

Flies, Sarah J. ;

Chen, Lieping .

BLOOD, 2008, 111 (07) :3635-3643

[5] Extended Co-Expression of Inhibitory Receptors by Human CD8 T-Cells Depending on Differentiation, Antigen-Specificity and Anatomical Localization [J].

Baitsch, Lukas ;

Legat, Amandine ;

Barba, Leticia ;

Marraco, Silvia A. Fuertes ;

Rivals, Jean-Paul ;

Baumgaertner, Petra ;

Christiansen-Jucht, Celine ;

Bouzourene, Hanifa ;

Rimoldi, Donata ;

Pircher, Hanspeter ;

Rufer, Nathalie ;

Matter, Maurice ;

Michielin, Olivier ;

Speiser, Daniel E. .

PLOS ONE, 2012, 7 (02)

[6] Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients [J].

Baitsch, Lukas ;

Baumgaertner, Petra ;

Devevre, Estelle ;

Raghav, Sunil K. ;

Legat, Amandine ;

Barba, Leticia ;

Wieckowski, Sebastien ;

Bouzourene, Hanifa ;

Deplancke, Bart ;

Romero, Pedro ;

Rufer, Nathalie ;

Speiser, Daniel E. .

JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (06) :2350-2360

[7] Restoring function in exhausted CD8 T cells during chronic viral infection [J].

Barber, DL ;

Wherry, EJ ;

Masopust, D ;

Zhu, BG ;

Allison, JP ;

Sharpe, AH ;

Freeman, GJ ;

Ahmed, R .

NATURE, 2006, 439 (7077) :682-687

[8] Coexpression of PD-1, 2B4, CD160 and KLRG1 on Exhausted HCV-Specific CD8+T Cells Is Linked to Antigen Recognition and T Cell Differentiation [J].

Bengsch, Bertram ;

Seigel, Bianca ;

Ruhl, Marianne ;

Timm, Joerg ;

Kuntz, Martin ;

Blum, Hubert E. ;

Pircher, Hanspeter ;

Thimme, Robert .

PLOS PATHOGENS, 2010, 6 (06)

[9] The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody [J].

Benson, Don M., Jr. ;

Bakan, Courtney E. ;

Mishra, Anjali ;

Hofmeister, Craig C. ;

Efebera, Yvonne ;

Becknell, Brian ;

Baiocchi, Robert A. ;

Zhang, Jianying ;

Yu, Jianhua ;

Smith, Megan K. ;

Greenfield, Carli N. ;

Porcu, Pierluigi ;

Devine, Steven M. ;

Rotem-Yehudar, Rinat ;

Lozanski, Gerard ;

Byrd, John C. ;

Caligiuri, Michael A. .

BLOOD, 2010, 116 (13) :2286-2294

[10] Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies [J].

Berger, Raanan ;

Rotem-Yehudar, Rinat ;

Slama, Gideon ;

Landes, Shimon ;

Kneller, Abraham ;

Leiba, Merav ;

Koren-Michowitz, Maya ;

Shimoni, Avichai ;

Nagler, Arnon .

CLINICAL CANCER RESEARCH, 2008, 14 (10) :3044-3051

← 1 2 3 4 5 6 7 8 9 10 →